We are live on ! Find out more
IP

Isthmus Partners Portfolio holdings

AUM $1.03B
1-Year Est. Return 22.86%
This Fund
S&P 500
This Quarter Est. Return
+8.85%
1 Year Est. Return
+22.86%
3 Year Est. Return
+61.07%
5 Year Est. Return
+76.25%
10 Year Est. Return
+352.5%
AUM
$856M
AUM Growth
+$57.3M
Cap. Flow
+$8.83M
Cap. Flow %
1.03%
Top 10 Hldgs %
21.26%
Holding
228
New
17
Increased
91
Reduced
46
Closed
11

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$14.6M
2
DXCM icon
DexCom
DXCM
+$13.1M
3
ABBV icon
AbbVie
ABBV
+$11.6M
4
INTC icon
Intel
INTC
+$2.57M
5
UPS icon
United Parcel Service
UPS
+$2.4M

Top Sells

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$15.2M
2
KVUE icon
Kenvue
KVUE
+$13.3M
3
DOC icon
Healthpeak Properties
DOC
+$9.01M
4
MCD icon
McDonald's
MCD
+$3.45M
5
VREX icon
Varex Imaging
VREX
+$1.78M

Sector Composition

Rank Sector Weight
1 Industrials 23.8%
2 Technology 16.48%
3 Consumer Discretionary 15.99%
4 Financials 14.18%
5 Healthcare 13.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VREX icon
226
Varex Imaging
VREX
$522M
-153,396
Closed -$1.78M

Similar funds

Isthmus Partners's Q2 2025 Portfolio in Review

As of Q2 2025, Isthmus Partners held 228 positions worth $856M, up 7.2% from $799M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Isthmus Partners's Q2 2025 filing shows 17 new, 91 increased, 46 reduced and 11 closed positions. Its largest new stake was DexCom: 167,387 shares worth $14.6M. The largest sale was Quest Diagnostics, an estimated $15.2M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Isthmus Partners's largest Q2 2025 buy was DexCom: 167,387 shares worth $14.6M.
  • Isthmus Partners added most to Alphabet (Google) Class A in Q2 2025, an estimated $14.6M increase.
  • Isthmus Partners's biggest Q2 2025 reduction was Healthpeak Properties, cutting an estimated $9.01M.
  • Isthmus Partners fully exited Quest Diagnostics in Q2 2025, selling an estimated $15.2M.
  • Isthmus Partners's ten largest holdings make up 21% of its $856M portfolio in Q2 2025.
  • Isthmus Partners opened 17 new positions and closed 11 in Q2 2025.
  • Isthmus Partners's portfolio value rose 7.2% quarter-over-quarter to $856M.

Based on Isthmus Partners's 13F filing for Q2 2025, filed 13 Aug 2025.